Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karthik Radhakrishnan Insider Profile
4 Followers
Karthik Radhakrishnan, CFO at Acer Therapeutics, holds 124.66K shares in Acer Therapeutics (Ticker: ACER).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-20.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Karthik Radhakrishnan's holdings
Insider Roles
CFO
Roles that Karthik Radhakrishnan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karthik Radhakrishnan
Karthik Radhakrishnan's Trading History
List of latest transactions for each holding click on a transaction to see Karthik Radhakrishnan's performance on stock
You May Also Like
Karthik Radhakrishnan insider profile FAQ
What is the percentage of profitable transactions made by Karthik Radhakrishnan?
The percentage of profitable transactions made by Karthik Radhakrishnan is 50%.
What is the average return per transaction made by Karthik Radhakrishnan?
The average return per transaction made by Karthik Radhakrishnan is -20.00%.
What stocks does Karthik Radhakrishnan hold?
Karthik Radhakrishnan holds: ACER stocks.
What was Karthik Radhakrishnan’s latest transaction?
Karthik Radhakrishnan latest transaction was an Uninformative Buy of ―.
What was Karthik Radhakrishnan's most profitable transaction?
Karthik Radhakrishnan’s most profitable transaction was an Informative Buy of ACER stock on August 9, 2013. The return on the trade was 8.70%.
What is Karthik Radhakrishnan's role in Acer Therapeutics?
Karthik Radhakrishnan's role in Acer Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.